
    
      This study will be performed in patients with blood pressure (BP) uncontrolled by existing
      antihypertensive drugs (including ARB) among hypertensive patients visiting outpatient clinic
      of medical institutions in Korea. The study enrollment number will be assigned to the
      subjects who provide a written consent to the use of personal information and meet the
      inclusion/exclusion criteria. Follow-up will be conducted for 12 weeks in total and
      prespecified study related data will be collected in the case report form.
    
  